title: Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release.
abstract: The endogenous, peptide ligand for the orphan receptors GPR7 and GPR8 was identified to be neuropeptide W (NPW). Because these receptors are expressed in brain and in particular in hypothalamus, we hypothesized that NPW might interact with neuroendocrine systems that control hormone release from the anterior pituitary gland. No significant effects of NPW were observed on the in vitro releases of prolactin (PRL), ACTH, or GH when log molar concentrations ranging from 1 pM to 100 nM NPW were incubated with dispersed anterior pituitary cells. However, NPW, when injected into the lateral cerebroventricle of conscious, unrestrained male rats, in a dose-related fashion elevated PRL and corticosterone and lowered GH levels in circulation. The threshold dose for all three effects was 1.0 nmol. We conclude that endogenous NPW may play a regulatory role in the organization of neuroendocrine signals accessing the anterior pituitary gland but does not itself act as a true releasing or inhibiting factor in the gland. Central administration of NPW23 also stimulated water drinking and food intake. The ability of exogenous peptide to decrease GH but stimulate PRL secretion and activate the hypothalamo-pituitary adrenal axis, together with the observed behavioral effects, suggests that endogenous NPW may play a role in the hypothalamic response to stress.
authors.affiliation: Pharmacological and Physiological Sciences, St. Louis University School of Medicine, 1402 South Grand Boulevard, St. Louis, MO 63104, USA.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Baker
authors.forename: Kara
authors.initials: K
authors.lastname: Cardinal
authors.forename: Cynthia
authors.initials: C
authors.lastname: Bober
authors.forename: Meghan M
authors.initials: MM
authors.lastname: Taylor
authors.forename: Willis K
authors.initials: WK
authors.lastname: Samson
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000818:Animals; D003243:Consciousness; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007276:Injections, Intraventricular; D008297:Male; D009479:Neuropeptides / Q000494:pharmacology*; D010903:Pituitary Gland, Anterior / Q000187:drug effects* / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: C467731:NPW protein, human; D009479:Neuropeptides; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone